Sarkhan ELBAYİYEV, Naci YILMAZ, Gülsüm KADIOĞLU ŞİMŞEK, Ezgi TURGUT, H. Gözde KANMAZ KUTMAN, Fuat Emre CANPOLAT

COVID-19 PCR Pozitif ve Negatif Anneden Doğan Bebeklerin Sistemik İmmün İndekslerinin Karşılaştırmalı Değerlendirilmesi - Neonatal Etkiler Öngörülebilir mi?

Amaç: Dünya Sağlık Örgütü’nün 11 Mart 2020 tarihinde pandemi olarak ilan ettiği Koronavirüs hastalığı-2019 (COVID-19), Şiddetli akut respiratuvar sendrom-Koronavirüs-2’nin neden olduğu bir durumdur ve olgu sayısı her gün giderek artmaktadır. Çalışmanın amacı COVID-19 pandemisi döneminde hassas popülasyon olan COVID-19 polimeraz zincir reaksiyonu (PCR) pozitif anneden doğan yenidoğan bebeklerinin SİSTEMİK immün- enflamasyon indeksleri (Sİİ) normal popülasyona göre farklılıklarının araştırılmasıdır. Gereç ve Yöntem: Mart 2019 ve Kasım 2021 tarihleri arasında Ankara Şehir Hastanesi’nde doğumdan önceki iki haftada COVID-19 PCR testi pozitif saptanan annelerden, ≥37 gestasyon haftasında doğan, nazal sürüntü ile alınan COVID-19 PCR testi negatif saptanan ve anne yanında olağan bakım verilen yenidoğanlar ile kontrol grubunda ≥37 gestasyon haftasında COVID-19 PCR testi negatif anneden doğan sağlıklı yenidoğanların bazal hematolojik parametreleri karşılaştırıldı. Bulgular: COVID-19 PCR pozitif anne bebekleri grubunda (n=86) sezaryen yöntemiyle doğum oranı daha fazlaydı (p

Comparative Evaluation of Systemic Immune Indexes in Infants Born to COVID-19 PCR Positive and Negative Mothers - Can Neonatal Effects Be Predicted?

Aim: The Coronavirus disease-2019 (COVID-19), declared as a pandemic by the World Health Organization on March 11, 2020, is a condition caused by Severe acute respiratory syndrome-Coronavirus-2, and the number of cases is increasing day by day. The aim of this study is to investigate the differences in systemic inflammatory indices of newborn babies born to COVID-19 polymerase chain reaction (PCR)-positive mothers, who constitute a sensitive population during the COVID-19 pandemic period, compared to the normal population. Materials and Methods: Between March 2019 and November 2021, in Ankara City Hospital, newborns who were born at ≥37 weeks of gestation to COVID-19 PCR positive mothers in the two weeks before birth and whose COVID-19 PCR tests were negative and were given usual care with mothers, basal hematological parameters were compared by taking healthy newborns born to COVID-19 PCR negative mothers at ≥37 weeks of gestation in the control group. Results: The rate of cesarean delivery was higher in the group (n=86) of babies of COVID-19 PCR positive mothers (p

PDF

___

1. Levy A, Yagil Y, Bursztyn M, Barkalifa R, Scharf S, Yagil C. ACE2 expression and activity are enhanced during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1953-61.
2. Hecht JL, Quade B, Deshpande V, Mino-Kenudson M, Ting DT, Desai N, et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod Pathol. 2020;33:2092-103.
3. Yoon SH, Kang JM, Ahn JG. Clinical outcomes of 201 neonates born to mothers with COVID-19: a systematic review. Eur Rev Med Pharmacol Sci. 2020;24:7804-15.
4. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809-15.
5. Capozza M, Salvatore S, Baldassarre ME, Inting S, Panza R, Fanelli M, et al. Perinatal Transmission and Outcome of Neonates Born to SARS-CoV- 2-Positive Mothers: The Experience of 2 Highly Endemic Italian Regions. Neonatology. 2021;118:665-71.
6. Dong L, Tian J, He S, Zhu C, Wang J, Liu C, et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA. 2020;323:1846-8.
7. Liu W, Cheng H, Wang J, Ding L, Zhou Z, Liu S, et al. Clinical Analysis of Neonates Born to Mothers with or without COVID-19: A Retrospective Analysis of 48 Cases from Two Neonatal Intensive Care Units in Hubei Province. Am J Perinatol. 2020;37:1317-23.
8. Akyıldız D, Çamur Z. Comparison of early postnatal clinical outcomes of newborns born to pregnant women with COVID-19: a case-control study. J Matern Fetal Neonatal Med. 2021:1-8.
9. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175:817-26.
10. Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer. 2020;67:e28745.
11. Raba AA, Abobaker A, Elgenaidi IS, Daoud A. Novel coronavirus infection (COVID-19) in children younger than one year: A systematic review of symptoms, management and outcomes. Acta Paediatr. 2020;109:1948-55.
12. Zhang C, Chu H, Pei YV, Zhang J. Laboratory Effects of COVID-19 Infection in Pregnant Women and Their Newborns: A Systematic Review and Meta- Analysis. Front Glob Womens Health. 2021;2:647072.
13. Wang X, Li X, Shang Y, Wang J, Zhang X, Su D, et al. Ratios of neutrophil- to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre. Epidemiol Infect. 2020;148:e211.
14. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020 Jul;84:106504.
15. Liang J, Nong S, Jiang L, Chi X, Bi D, Cao J, et al. Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment. J Clin Lab Anal. 2021;35:e23609.
16. Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92:1533-41.
17. Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020;25:5725.
18. Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to- Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12:448-53.
19. Ceran B, Alyamaç Dizdar E, Beşer E, Karaçağlar NB, Sarı FN. Diagnostic Role of Systemic Inflammatory Indices in Infants with Moderate-to-Severe Hypoxic Ischemic Encephalopathy. Am J Perinatol. 2021 Oct 19.
20. Coronavirus disease (covid-19): Pregnancy and childbirth [Internet]. World Health Organization. World Health Organization. Available from: https:// www.who.int/news-room/questions-and-answers/item/coronavirus- disease-covid-19-pregnancy-and-childbirth
21. Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:36-46.
22. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81.
23. Akdogan M, Ustundag Y, Cevik SG, Dogan P, Dogan N. Correlation between systemic immune-inflammation index and routine hemogram-related inflammatory markers in the prognosis of retinopathy of prematurity. Indian J Ophthalmol. 2021;69:2182-7.
24. Lamba V, Lien J, Desai J, Talati AJ. Management and short-term outcomes of neonates born to mothers with active perinatal SARS-CoV-2 infection. BMC Pediatr. 2021;21:400.
25. Wróblewska-Seniuk K, Basiukajć A, Wojciechowska D, Telge M, Miechowicz I, Mazela J. Clinical Characteristics of Newborns Born to Mothers with COVID-19. J Clin Med. 2021;10:4383.
26. Kyle MH, Glassman ME, Khan A, Fernández CR, Hanft E, Emeruwa UN, et al. A review of newborn outcomes during the COVID-19 pandemic. Semin Perinatol. 2020;44:151286.
27. More K, Aiyer S, Goti A, Parikh M, Sheikh S, Patel G, et al. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series. Eur J Pediatr. 2022;181:1883-98.